W3B, I could be wrong, but I think you will find they specifically severed the sciatic nerves of the rats and apply CelGro (and in a control group used the FDA approved market leading nerve repair device), let the nerve grow back and dissect (the poor dead rat) after 4 weeks and study the biological repair, particularly in comparison to the existing market device.
Its a good point you make. I encourage investors to look at this study and look at the superior end result from CelGro vs the market standard product. The CelGro repair looks far more like a normal nerve under macroscopic focus than the comparator product. The images are undeniable to the human eye. Remplir appears to give a far superior repair.
OCC_CelGro_Study_Results_Open_Up_New_US_Market_Access_Strategy.pdf
- Forums
- ASX - By Stock
- OCC
- Ann: Positive CelGro Nerve Regeneration Results
Ann: Positive CelGro Nerve Regeneration Results, page-41
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.49M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21373 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 14885 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 21373 | 0.375 |
3 | 65388 | 0.365 |
9 | 253746 | 0.360 |
4 | 42268 | 0.355 |
5 | 73573 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 14885 | 2 |
0.375 | 27860 | 2 |
0.380 | 39868 | 3 |
0.390 | 25792 | 5 |
0.395 | 14908 | 2 |
Last trade - 09.49am 15/08/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online